Characteristics | No. of patients (%) |
---|---|
Age (years) | |
Median | 47 |
Range | 25–84 |
Stage (AJCC) | |
I/II | 188 (50) |
III/IV | 188 (50) |
Histological grade | |
1 | 108 (29) |
2 | 179 (48) |
3 | 89 (23) |
Missing | 0 (0) |
ER | |
Negative | 169 (45) |
Positive | 207 (55) |
Missing | 0 (0) |
PR | |
Negative | 124 (33) |
Positive | 252 (67) |
Missing | 0 (0) |
HER2 | |
Negative | 211 (56) |
Positive | 165 (44) |
Missing | 0 |
Luminal | 288 (77) |
HER-2 subtypes | 53 (14) |
TNBC | 35 (9) |
Ki-67 | |
Low expressiona | 281 (75) |
High expressionb | 88 (23) |
Missing | 7 (2) |
Mutational P53 | |
Low expressiona | 196 (52) |
High expressionb | 165 (44) |
Missing | 15 (4) |
VEGF | |
Low expressiona | 302 (80) |
High expressionb | 64 (17) |
Missing | 10 (3) |
Radiotherapy | |
Yes | 91 (24) |
No | 285 (76) |
Chemotherapy | |
Yes | 367 (98) |
No | 9 (2) |